125 related articles for article (PubMed ID: 7839081)
1. Histamine sensitivity in the nasal mucosa during four-week use of oxymetazoline.
Graf P; Juto JE
Rhinology; 1994 Sep; 32(3):123-6. PubMed ID: 7839081
[TBL] [Abstract][Full Text] [Related]
2. Decongestion effect and rebound swelling of the nasal mucosa during 4-week use of oxymetazoline.
Graf P; Juto JE
ORL J Otorhinolaryngol Relat Spec; 1994; 56(3):157-60. PubMed ID: 7515487
[TBL] [Abstract][Full Text] [Related]
3. Four-week use of oxymetazoline nasal spray (Nezeril) once daily at night induces rebound swelling and nasal hyperreactivity.
Graf P; Hallén H; Juto JE
Acta Otolaryngol; 1995 Jan; 115(1):71-5. PubMed ID: 7762389
[TBL] [Abstract][Full Text] [Related]
4. The effects of oxymetazoline on lysozyme secretion from the human nasal mucosa.
Browning S; Housley D; Richards R; Eccles R
Acta Otolaryngol; 1997 Nov; 117(6):851-5. PubMed ID: 9442826
[TBL] [Abstract][Full Text] [Related]
5. Nasal hyperreactivity. A histamine provocation model.
Ohm M; Juto JE
Rhinology; 1993 Jun; 31(2):53-5. PubMed ID: 8362169
[TBL] [Abstract][Full Text] [Related]
6. A test for objective diagnosis of nasal hyperreactivity.
Hallén H; Juto JE
Rhinology; 1993 Mar; 31(1):23-5. PubMed ID: 8321978
[TBL] [Abstract][Full Text] [Related]
7. Thresholds in nasal histamine challenge in patients with allergic rhinitis, patients with hyperreflectory rhinopathy, and healthy volunteers.
Wuestenberg EG; Hauswald B; Huettenbrink KB
Am J Rhinol; 2004; 18(6):371-5. PubMed ID: 15706984
[TBL] [Abstract][Full Text] [Related]
8. One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment.
Graf P; Hallén H
ORL J Otorhinolaryngol Relat Spec; 1997; 59(1):39-44. PubMed ID: 9104748
[TBL] [Abstract][Full Text] [Related]
9. Sustained use of xylometazoline nasal spray shortens the decongestive response and induces rebound swelling.
Graf P; Juto JE
Rhinology; 1995 Mar; 33(1):14-7. PubMed ID: 7540314
[TBL] [Abstract][Full Text] [Related]
10. Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays.
Graf P; Hallén H
Laryngoscope; 1996 May; 106(5 Pt 1):605-9. PubMed ID: 8628089
[TBL] [Abstract][Full Text] [Related]
11. Nasal mucosa reaction. A model for mucosal reaction during challenge.
Hallén H; Juto JE
Rhinology; 1992 Jun; 30(2):129-33. PubMed ID: 1411098
[TBL] [Abstract][Full Text] [Related]
12. Benzalkonium chloride in a decongestant nasal spray aggravates rhinitis medicamentosa in healthy volunteers.
Graf P; Hallén H; Juto JE
Clin Exp Allergy; 1995 May; 25(5):395-400. PubMed ID: 7553241
[TBL] [Abstract][Full Text] [Related]
13. Correlation between objective nasal mucosal swelling and estimated stuffiness during long-term use of vasoconstrictors.
Graf P; Juto JE
ORL J Otorhinolaryngol Relat Spec; 1994; 56(6):334-9. PubMed ID: 7530821
[TBL] [Abstract][Full Text] [Related]
14. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.
Watanabe H; Foo TH; Djazaeri B; Duncombe P; Mackay IS; Durham SR
Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657
[TBL] [Abstract][Full Text] [Related]
15. Effects of intranasal histamine on the cough reflex in subjects with allergic rhinitis.
Plevkova J; Brozmanova M; Pecova R; Tatar M
J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():185-95. PubMed ID: 16204792
[TBL] [Abstract][Full Text] [Related]
16. Topical azelastine has a 12-hour duration of action as assessed by histamine challenge-induced exudation of alpha 2-macroglobulin into human nasal airways.
Greiff L; Andersson M; Svensson C; Persson CG
Clin Exp Allergy; 1997 Apr; 27(4):438-44. PubMed ID: 9146938
[TBL] [Abstract][Full Text] [Related]
17. Effect of oxymetazoline nose drops on vascular permeability of the nasal mucosa in the rabbit after provocation with leukotriene B4.
Bende M; Hansell P; Intaglietta M; Arfors KE
ORL J Otorhinolaryngol Relat Spec; 1992; 54(5):270-4. PubMed ID: 1336840
[TBL] [Abstract][Full Text] [Related]
18. Benzalkonium chloride in nasal decongestive sprays has a long-lasting adverse effect on the nasal mucosa of healthy volunteers.
Hallén H; Graf P
Clin Exp Allergy; 1995 May; 25(5):401-5. PubMed ID: 7553242
[TBL] [Abstract][Full Text] [Related]
19. Time-dependent observations of secretion marker levels in nasal secretion after histamine and methacholine provocations.
Pupek M; Mikulewicz W; Mielnik J; Batycka B; Katnik-Prastowska I
Arch Immunol Ther Exp (Warsz); 2003; 51(4):259-65. PubMed ID: 12956435
[TBL] [Abstract][Full Text] [Related]
20. One year follow-up of patients with rhinitis medicamentosa after vasoconstrictor withdrawal.
Graf PM; Hallén H
Am J Rhinol; 1997; 11(1):67-72. PubMed ID: 9065350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
